CS
RVMD icon

Candriam SCA’s Revolution Medicines RVMD Stock Holding History

Candriam SCA’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$104M Sell
556,392
-24,285
-4% -$3.55M 0.47% 41
2026
Q1 		$56.5M Sell
580,677
-450,315
-44% -$45.5M 0.29% 76
2025
Q4 		$82.1M Buy
1,030,992
+162,268
+19% +$10.6M 0.41% 51
2025
Q3 		$40.6M Buy
868,724
+149,211
+21% +$5.84M 0.21% 107
2025
Q2 		$26.5M Buy
719,513
+64,379
+10% +$2.47M 0.15% 128
2025
Q1 		$23.2M Sell
655,134
-1,606
-0.2% -$65.2K 0.15% 146
2024
Q4 		$28.7M Buy
656,740
+92,958
+16% +$4.69M 0.17% 125
2024
Q3 		$25.6M Buy
563,782
+9,448
+2% +$411K 0.15% 145
2024
Q2 		$21.5M Sell
554,334
-29,616
-5% -$1.11M 0.13% 157
2024
Q1 		$18.8M Sell
583,950
-23,000
-4% -$682K 0.12% 175
2023
Q4 		$17.4M Buy
606,950
+45,002
+8% +$1.08M 0.12% 176
2023
Q3 		$15.6M Sell
561,948
-18,000
-3% -$534K 0.11% 172
2023
Q2 		$15.5M Sell
579,948
-26,384
-4% -$647K 0.11% 192
2023
Q1 		$12.1M Sell
606,332
-126,173
-17% -$3.11M 0.08% 232
2022
Q4 		$17.4M Hold
732,505
– – 0.12% 189
2022
Q3 		$14.4M Buy
732,505
+177,250
+32% +$3.9M 0.1% 207
2022
Q2 		$10.8M Buy
555,255
+121,051
+28% +$2.36M 0.09% 215
2022
Q1 		$11.1M Sell
434,204
-16,178
-4% -$352K 0.08% 242
2021
Q4 		$11.3M Sell
450,382
-39,000
-8% -$1.1M 0.07% 246
2021
Q3 		$13.5M Buy
489,382
+95,312
+24% +$2.77M 0.09% 230
2021
Q2 		$12.5M Buy
394,070
+394,060
+3,940,600% +$13.8M 0.09% 257
2021
Q1 		$0 Buy
+10
New +$448 ﹤0.01% 819

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Candriam SCA's RVMD Position: Q2 2026 in Review

Candriam SCA reduced its Revolution Medicines (RVMD) stake by 4.2% in Q2 2026, selling an estimated $3.55M and leaving 556,392 shares worth $104M. The position accounts for 0.47% of the portfolio, ranked #41.

Candriam SCA first reported a position in RVMD in Q1 2021 and has held it in 22 quarters since. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Candriam SCA held 556,392 shares of Revolution Medicines worth $104M as of Q2 2026.
  • Candriam SCA sold 24,285 Revolution Medicines shares in Q2 2026, an estimated $3.55M.
  • Revolution Medicines made up 0.47% of Candriam SCA's portfolio in Q2 2026, its #41 holding.
  • Candriam SCA first reported a position in Revolution Medicines in Q1 2021 and has held it in 22 quarters since.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.